Policy / Pricing FDA floats new clinical trial reforms; Takeda punts Denali brain drug BioPharma DiveIn its budget request, the agency proposed a way to speed up early drug testing and help smaller biotech firms.Policy / PricingRead full story pharminent April 6, 2026 (Last updated: April 6, 2026) BioPharma Dive In its budget request, the agency proposed a way to speed up early drug testing and help smaller biotech firms. Policy / PricingRead full story Post navigation Previous: Neurocrine to acquire Prader-Will drug in $2.9B Soleno buyoutNext: Amgen scores with new thyroid eye disease formulation Related Stories Policy / Pricing UniQure, Replimune shares rise as FDA’s Makary exits, but path forward unchanged pharminent May 13, 2026 Policy / Pricing EU agrees plan to tackle essential medicine shortages pharminent May 12, 2026 Policy / Pricing 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders (NEW Live Video Webinar) pharminent May 12, 2026
